Barry S. Ticho

2021

In 2021, Barry S. Ticho earned a total compensation of $3.1M as Chief Medical Officer at Stoke Therapeutics.

Compensation breakdown

Bonus$8,966
Non-Equity Incentive Plan$197,257
Option Awards$2,484,499
Salary$448,308
Other$10,461
Total$3,149,491

Ticho received $2.5M in option awards, accounting for 79% of the total pay in 2021.

Ticho also received $9K in bonus, $197.3K in non-equity incentive plan, $448.3K in salary and $10.5K in other compensation.

Rankings

In 2021, Barry S. Ticho's compensation ranked 4,246th out of 12,415 executives tracked by ExecPay. In other words, Ticho earned more than 65.8% of executives.

ClassificationRankingPercentile
All
4,246
out of 12,415
66th
Division
Manufacturing
1,750
out of 5,505
68th
Major group
Chemicals And Allied Products
731
out of 2,375
69th
Industry group
Drugs
653
out of 2,096
69th
Industry
Pharmaceutical Preparations
461
out of 1,546
70th
Source: SEC filing on April 27, 2023.

Ticho's colleagues

We found two more compensation records of executives who worked with Barry S. Ticho at Stoke Therapeutics in 2021.

2021

Edward Kaye

Stoke Therapeutics

Chief Executive Officer

2021

Stephen Tulipano

Stoke Therapeutics

Chief Financial Officer

News

In-depth

You may also like